Status:
UNKNOWN
The MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital
Collaborating Sponsors:
Zhuhai livzon cynvenio diagnostics LTD
Conditions:
Pulmonary Nodule, Solitary
Eligibility:
All Genders
18+ years
Brief Summary
* The purpose of the study is the identification of the efficacy of MDA Test to Differentiate of Benign and Malignant Pulmonary Nodules. * In this study, the investigators are going to validate the ef...
Detailed Description
* Current state-of-the-art lung cancer early screening utilizes low-dose CT scan to identify lung nodules smaller than 3 cm in diameter. However, it's still a clinical challenge to differentiate betwe...
Eligibility Criteria
Inclusion
- 18 years old or above
- single pulmonary nodule found by CT scan.
- the diameter of the pulmonary nodule is between 5mm to 30mm.
- plan to accept pneumonectomy due to the pulmonary nodule.
- agree to sign informed consent
Exclusion
- fail to understand or agree to sign informed consent.
- pregnant or lactating women.
- the diameter of the pulmonary nodule is more than 30mm.
- there are 2 or more pulmonary nodules in one single patient.
Key Trial Info
Start Date :
May 3 2018
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2019
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT03790735
Start Date
May 3 2018
End Date
June 1 2019
Last Update
January 2 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tianjin Medical University Cancer Institute & Hospital
Tianjin, China